Camber launches generic Velcade
Bortezomib for injection is an oncology medication.
Camber is introducing bortezomib for injection, which is a generic of Velcade.
Bortezomib for Injection is a proteasome inhibitor indicated for:
- Treatment of adult patients with multiple myeloma; and
- Treatment of adult patients with mantle cell lymphoma.
[Read more: Camber debuts generic Bentyl]
Bortezomib for injection is available from Camber in a 3.5 mg strength, and it is packaged in a single-dose vial.
[Read more: Camber - Number 1 in Generic Approvals]